To Assess the Impact of theERAS Consensus on Patients With Endoscopic Pituitary Tumor Surgery

To Assess the Impact of the Enhanced Recovery After Surgery (ERAS) Consensus on the Effectiveness and Prognosis of Patients With Endoscopic Pituitary Tumor Surgery

The goal of this observational study is to evaluate the effectiveness and impact of Enhanced Recovery After Surgery (ERAS) on patients with pituitary gland tumors.

The goal of this observational study is to evaluate the effectiveness and impact of Enhanced Recovery After Surgery (ERAS) on patients with pituitary gland tumors. This study is particularly significant as ERAS has been a prominent focus in international medical treatment, emphasizing improved patient recovery and safety. The main questions it aims to answer are:

How does ERAS affect the effectiveness and prognosis of patients with pituitary gland tumors? Which specific inspection and evaluation items within the ERAS protocol genuinely assist patients? Participants in this study will undergo various ERAS protocols, including pre-operative to post-operative rehabilitation measures, pain management, surgical techniques, and early resumption of eating and activities. This comprehensive approach is designed to reduce complications, shorten hospital stays, and speed up patient recovery.

Additionally, this study will conduct a thorough statistical analysis to determine which aspects of the ERAS protocol are most beneficial. By comparing the outcomes of patients undergoing the ERAS protocol with those who do not, researchers aim to understand better the balance between ERAS and the Choosing Wisely initiative, which advocates for reducing unnecessary medical interventions.

This research is crucial in advancing medical knowledge and practice, particularly in managing pituitary gland tumors, and contributes to the broader goals of enhancing medical quality and patient safety.

Inclusion Criteria:

• Clinical diagnosis of pituitary tumors
• To sign a written informed consent form

Exclusion Criteria:

• Diagnosed with other malignant tumors
• Severe infections, such as osteomyelitis, acute inflammation at the affected site, or open wounds at the treatment area
• Pregnant women
• Coagulation disorders or those taking anticoagulant medication
• Other central nervous system disorders, alcohol addiction, other addictive drugs, or mental illness that may affect clinical assessment
• Deemed unsuitable for surgical treatment or unable to comply with clinical evaluation upon assessment